On Jul. 19, 2022, the National Institutes of Health (NIH) announced that although COVID-19 booster vaccinations in adults…
On Jul. 13, 2022, Moderna announced it has now demonstrated significantly higher antibody titers against all tested variants,…
On Jul. 5, 2022, Tgen and Northern Arizona University announced that a research team found that the vaccine…
On Jul. 5, 2022, the National Institutes of Health released a study that described the immune response triggered…
Play the COVID-19 Wheel of Fortune and see how lucky you are! You have two wheels to choose…
On Apr. 7, 2022, Moderna and IAVI announced a collaboration to employ mRNA technology to meet the challenge…
On Feb. 17, 2022, after studying blood samples from 244 patients hospitalized for COVID-19, a group of researchers,…
On Jan. 28, 2022, the WHO announced that COVID-19 information had reached 1,292,209 people through Viamoﾒs 3-2-1 Platform…
On Jan. 27, 2022, NIAID announced that a clinical trial found that the combination of remdesivir plus a…
On Jan. 25, 2022, researchers at the University of Missouri announced they had identified the highly prevalent, specific…
On Jan. 24, 2022, Pfizer and BioNTech announced the publication of new results from two laboratory studies demonstrating…
On Jan. 20, 2022, scientists from the National Institute of Allergy and Infectious Diseases (NIAID) announced that they…
On Dec. 8, 2021, Pfizer and BioNTech announced results from an initial laboratory study demonstrating that serum antibodies…
On Dec. 7, 2021, Rockefeller University scientists announced a study had demonstrated the therapeutic potential of an unusual…
On Nov. 23, 2021, the World Health Organization’s COVID-19 Technology Access Pool and the Medicines Patent Pool finalized…
On Oct. 27, 2021, Fulgent Genetics announced that it has launched an antibody test for COVID-19 which will…
On Oct. 21, 2021, the National Institutes of Health (NIH) announced that a booster dose of the mRNA-1273…
On Oct. 11, 2021, Merck and Ridgeback Biotherapeutics announced that Merck had submitted an Emergency Use Authorization (EUA)…
On Oct. 11, 2021, scientists at Washington University School of Medicine in St. Louis announced they had developed…
On Oct. 6, 2021, Lumen Bioscience announced new development funding from the US Army for its Covid-19 monoclonal…
On Oct. 5, 2021, PerkinElmer announced that the U.S. Food and Drug Administration had provided Emergency Use Authorization…
On Sept. 27, 2021, Pfizer announced the start of the Phase 2/3 EPIC-PEP (Evaluation of Protease Inhibition for…
On Sept. 23, 2021, Twist Bioscience reported that its internally-discovered antibody candidate TB202-3 (CoVIC-094), demonstrated potent binding to…
On Sept. 15, 2021, InBios announced that it had received Emergency Use Authorization from the U.S. Food and…
On Sept. 14, 2021, the U.S. Department of Defense in coordination with the Department of Health and Human…
On Sept. 14, 2021, the National Institutes of Health (NIH) announced that an international project called the COVID…
On Sept. 14, 2021, Regeneron announced an agreement with the U.S. Department of Health and Human Services and…
On Aug. 30, 2021, AXIM Biotechnologies announced that the Company’s manufacturing partner Empowered Diagnostics had filed an amended…
On Aug. 30, 2021, Oragenics announced that the stabilized pre-fusion spike protein trimer produced by its Canadian collaborator…
On Aug. 30, 2021, the Mayo Clinic reported that in an observational study the combination of casirivimab and…